HKU Recognised in 2025 Hong Kong Top Ten Innovation & Technology Breakthroughs

Three HKU-led projects were selected among the “2025 Hong Kong Top Ten Innovation & Technology Breakthroughs” by the Beijing-Hong Kong Academic Exchange Centre, including two landmark medical innovations from HKUMed:

• First-in-class “dual immune” therapy for hepatocellular carcinoma – led by Professor Thomas YAU, which has gained international approval and significantly extends overall survival for patients.
• Light-sensitive hybrid γδ-T-cell exosome immunotherapy for melanoma – led by Professor Wenwei Tu, offering a scalable, off-the-shelf cancer immunotherapy approach.

A third recognised achievement is the first-ever detection of the “first heartbeat” periodic oscillation of a newborn neutron star, providing direct observational evidence of magnetar-driven gamma-ray bursts.

These honours highlight HKU and HKUMed’s strength in both transformative clinical innovation and frontier science.

Full list of awardees: https://www.bhkaec.org.hk/a/147499-cht